D'Orazio & Associates’s Medpace MEDP Stock Holding History

D'Orazio & Associates’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$38K	–	452
2021 Q3	$38K	Hold	200	–	–	0.01%	244
2021 Q2	$35K	Hold	200	–	–	0.01%	201
2021 Q1	$33K	Hold	200	–	–	0.01%	198
2020 Q4	$28K	Hold	200	–	–	0.01%	198
2020 Q3	$22K	Hold	200	–	–	0.01%	192
2020 Q2	$19K	Hold	200	–	–	0.01%	199
2020 Q1	$15K	Hold	200	–	–	0.01%	200
2019 Q4	$17K	Hold	200	–	–	0.01%	222
2019 Q3	$17K	Hold	200	–	–	0.01%	218
2019 Q2	$13K	Hold	200	–	–	﹤0.01%	224
2019 Q1	$12K	Hold	200	–	–	﹤0.01%	224
2018 Q4	$11K	Buy	+200	New	+$11K	﹤0.01%	216

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

D'Orazio & Associates's MEDP Position: Q4 2021 in Review

D'Orazio & Associates sold out of Medpace (MEDP) in Q4 2021, closing a stake of 200 shares — an estimated $38K sold.

D'Orazio & Associates first reported a position in MEDP in Q4 2018 and held it in 12 quarters. The position peaked at $38K in Q3 2021. 386 funds tracked by Wall St. Rank hold MEDP as of Q4 2021.

D'Orazio & Associates reported no remaining Medpace position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 200 Medpace shares in Q4 2021, an estimated $38K.
D'Orazio & Associates first reported a position in Medpace in Q4 2018 and held it in 12 quarters.
D'Orazio & Associates's Medpace position peaked at $38K in Q3 2021.
386 funds tracked by Wall St. Rank held Medpace as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.